nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—CYP2D6—breast cancer	0.0975	0.301	CbGaD
Dronedarone—CYP3A4—breast cancer	0.0836	0.258	CbGaD
Dronedarone—ALB—breast cancer	0.0729	0.225	CbGaD
Dronedarone—ABCB1—breast cancer	0.0696	0.215	CbGaD
Dronedarone—ABCB1—Toremifene—breast cancer	0.0222	0.0703	CbGbCtD
Dronedarone—CYP3A4—Exemestane—breast cancer	0.0192	0.0608	CbGbCtD
Dronedarone—CYP2D6—Idarubicin—breast cancer	0.0173	0.0549	CbGbCtD
Dronedarone—CYP3A4—Letrozole—breast cancer	0.0163	0.0517	CbGbCtD
Dronedarone—ABCB1—Lapatinib—breast cancer	0.0162	0.0513	CbGbCtD
Dronedarone—CYP3A4—Anastrozole—breast cancer	0.0145	0.0461	CbGbCtD
Dronedarone—CYP3A4—Toremifene—breast cancer	0.0133	0.0421	CbGbCtD
Dronedarone—CYP3A4—Fulvestrant—breast cancer	0.0124	0.0392	CbGbCtD
Dronedarone—ALB—Irinotecan—breast cancer	0.0119	0.0377	CbGbCtD
Dronedarone—ALB—Fluorouracil—breast cancer	0.0114	0.0362	CbGbCtD
Dronedarone—CYP3A4—Thiotepa—breast cancer	0.011	0.0349	CbGbCtD
Dronedarone—CYP3A4—Ixabepilone—breast cancer	0.0101	0.0319	CbGbCtD
Dronedarone—CYP3A4—Lapatinib—breast cancer	0.0097	0.0307	CbGbCtD
Dronedarone—ABCB1—Vinorelbine—breast cancer	0.00898	0.0285	CbGbCtD
Dronedarone—CYP2D6—Vinorelbine—breast cancer	0.00846	0.0268	CbGbCtD
Dronedarone—ABCB1—Tamoxifen—breast cancer	0.00811	0.0257	CbGbCtD
Dronedarone—ABCB1—Mitoxantrone—breast cancer	0.00791	0.0251	CbGbCtD
Dronedarone—CYP2D6—Tamoxifen—breast cancer	0.00764	0.0242	CbGbCtD
Dronedarone—CYP3A4—Raloxifene—breast cancer	0.00735	0.0233	CbGbCtD
Dronedarone—ABCB1—Gemcitabine—breast cancer	0.00698	0.0221	CbGbCtD
Dronedarone—ABCB1—Paclitaxel—breast cancer	0.00631	0.02	CbGbCtD
Dronedarone—ALB—Methotrexate—breast cancer	0.0063	0.02	CbGbCtD
Dronedarone—ABCB1—Irinotecan—breast cancer	0.00622	0.0197	CbGbCtD
Dronedarone—ABCB1—Vinblastine—breast cancer	0.00553	0.0175	CbGbCtD
Dronedarone—CYP3A4—Vinorelbine—breast cancer	0.00538	0.0171	CbGbCtD
Dronedarone—CYP2D6—Vinblastine—breast cancer	0.00521	0.0165	CbGbCtD
Dronedarone—CYP3A4—Tamoxifen—breast cancer	0.00486	0.0154	CbGbCtD
Dronedarone—CYP3A4—Mitoxantrone—breast cancer	0.00474	0.015	CbGbCtD
Dronedarone—ABCB1—Docetaxel—breast cancer	0.00456	0.0145	CbGbCtD
Dronedarone—CYP3A4—Paclitaxel—breast cancer	0.00378	0.012	CbGbCtD
Dronedarone—CYP3A4—Irinotecan—breast cancer	0.00373	0.0118	CbGbCtD
Dronedarone—ABCB1—Doxorubicin—breast cancer	0.0034	0.0108	CbGbCtD
Dronedarone—CYP3A4—Vinblastine—breast cancer	0.00332	0.0105	CbGbCtD
Dronedarone—ABCB1—Methotrexate—breast cancer	0.00329	0.0104	CbGbCtD
Dronedarone—CYP2D6—Doxorubicin—breast cancer	0.0032	0.0102	CbGbCtD
Dronedarone—CYP3A4—Docetaxel—breast cancer	0.00273	0.00866	CbGbCtD
Dronedarone—KCNK2—mammary gland—breast cancer	0.00268	0.0464	CbGeAlD
Dronedarone—CACNB4—nipple—breast cancer	0.0025	0.0433	CbGeAlD
Dronedarone—CACNB3—mammary gland—breast cancer	0.00232	0.0401	CbGeAlD
Dronedarone—HCN3—pituitary gland—breast cancer	0.00222	0.0384	CbGeAlD
Dronedarone—HCN3—adipose tissue—breast cancer	0.00221	0.0382	CbGeAlD
Dronedarone—HCN2—pituitary gland—breast cancer	0.00208	0.036	CbGeAlD
Dronedarone—HCN2—adipose tissue—breast cancer	0.00207	0.0358	CbGeAlD
Dronedarone—CYP3A4—Doxorubicin—breast cancer	0.00204	0.00646	CbGbCtD
Dronedarone—CACNB3—nipple—breast cancer	0.00192	0.0332	CbGeAlD
Dronedarone—HCN2—adrenal gland—breast cancer	0.00186	0.0321	CbGeAlD
Dronedarone—Amiodarone—THRB—breast cancer	0.00181	0.517	CrCbGaD
Dronedarone—KCNK2—adipose tissue—breast cancer	0.00121	0.0209	CbGeAlD
Dronedarone—CACNB3—endometrium—breast cancer	0.00116	0.02	CbGeAlD
Dronedarone—CACNB1—adipose tissue—breast cancer	0.00109	0.0188	CbGeAlD
Dronedarone—KCNK2—adrenal gland—breast cancer	0.00108	0.0187	CbGeAlD
Dronedarone—CACNB3—uterus—breast cancer	0.00107	0.0184	CbGeAlD
Dronedarone—CACNB3—pituitary gland—breast cancer	0.00105	0.0181	CbGeAlD
Dronedarone—CACNB3—adipose tissue—breast cancer	0.00104	0.018	CbGeAlD
Dronedarone—CACNB1—adrenal gland—breast cancer	0.000975	0.0169	CbGeAlD
Dronedarone—ALB—mammary gland—breast cancer	0.000974	0.0169	CbGeAlD
Dronedarone—CACNB3—female reproductive system—breast cancer	0.000958	0.0166	CbGeAlD
Dronedarone—CACNB3—adrenal gland—breast cancer	0.000935	0.0162	CbGeAlD
Dronedarone—CACNB1—female gonad—breast cancer	0.000909	0.0157	CbGeAlD
Dronedarone—CACNB3—female gonad—breast cancer	0.000872	0.0151	CbGeAlD
Dronedarone—ADRA1D—epithelium—breast cancer	0.000751	0.013	CbGeAlD
Dronedarone—CACNB2—pituitary gland—breast cancer	0.000703	0.0122	CbGeAlD
Dronedarone—KCNK2—lymph node—breast cancer	0.000649	0.0112	CbGeAlD
Dronedarone—Dofetilide—CYP3A4—breast cancer	0.000636	0.181	CrCbGaD
Dronedarone—CACNB2—adrenal gland—breast cancer	0.000628	0.0109	CbGeAlD
Dronedarone—KCNH2—nipple—breast cancer	0.000619	0.0107	CbGeAlD
Dronedarone—CACNA1D—pituitary gland—breast cancer	0.000615	0.0106	CbGeAlD
Dronedarone—ADRA2C—nipple—breast cancer	0.00061	0.0106	CbGeAlD
Dronedarone—CACNB1—lymph node—breast cancer	0.000584	0.0101	CbGeAlD
Dronedarone—CACNA1C—pituitary gland—breast cancer	0.000567	0.00982	CbGeAlD
Dronedarone—CACNA1C—adipose tissue—breast cancer	0.000565	0.00978	CbGeAlD
Dronedarone—CACNB3—lymph node—breast cancer	0.00056	0.0097	CbGeAlD
Dronedarone—ADRA1D—female reproductive system—breast cancer	0.000558	0.00966	CbGeAlD
Dronedarone—CACNA1D—adrenal gland—breast cancer	0.000549	0.00951	CbGeAlD
Dronedarone—CACNA1C—female reproductive system—breast cancer	0.000519	0.00899	CbGeAlD
Dronedarone—CACNA1C—adrenal gland—breast cancer	0.000507	0.00877	CbGeAlD
Dronedarone—ADRA2A—nipple—breast cancer	0.000487	0.00843	CbGeAlD
Dronedarone—CACNA1D—endocrine gland—breast cancer	0.000476	0.00824	CbGeAlD
Dronedarone—ADRA1D—endocrine gland—breast cancer	0.000472	0.00817	CbGeAlD
Dronedarone—ADRB1—adipose tissue—breast cancer	0.000441	0.00763	CbGeAlD
Dronedarone—CACNA1C—endocrine gland—breast cancer	0.000439	0.00761	CbGeAlD
Dronedarone—ADRA1A—epithelium—breast cancer	0.000431	0.00747	CbGeAlD
Dronedarone—ADRB1—female reproductive system—breast cancer	0.000405	0.00702	CbGeAlD
Dronedarone—ALB—adrenal gland—breast cancer	0.000393	0.00681	CbGeAlD
Dronedarone—CACNB2—lymph node—breast cancer	0.000377	0.00652	CbGeAlD
Dronedarone—KCNH2—endometrium—breast cancer	0.000374	0.00647	CbGeAlD
Dronedarone—ADRA2C—endometrium—breast cancer	0.000369	0.00638	CbGeAlD
Dronedarone—Amiodarone—CYP1A1—breast cancer	0.000363	0.103	CrCbGaD
Dronedarone—ADRA1A—adipose tissue—breast cancer	0.000349	0.00603	CbGeAlD
Dronedarone—KCNH2—uterus—breast cancer	0.000344	0.00596	CbGeAlD
Dronedarone—ADRB1—endocrine gland—breast cancer	0.000343	0.00594	CbGeAlD
Dronedarone—ADRA2C—uterus—breast cancer	0.00034	0.00588	CbGeAlD
Dronedarone—KCNH2—pituitary gland—breast cancer	0.000338	0.00585	CbGeAlD
Dronedarone—ADRA2C—pituitary gland—breast cancer	0.000334	0.00577	CbGeAlD
Dronedarone—ADRA2C—adipose tissue—breast cancer	0.000332	0.00575	CbGeAlD
Dronedarone—CACNA1D—lymph node—breast cancer	0.000329	0.0057	CbGeAlD
Dronedarone—ADRA1A—adrenal gland—breast cancer	0.000313	0.00541	CbGeAlD
Dronedarone—KCNH2—female reproductive system—breast cancer	0.000309	0.00536	CbGeAlD
Dronedarone—CACNA1C—lymph node—breast cancer	0.000304	0.00526	CbGeAlD
Dronedarone—KCNH2—adrenal gland—breast cancer	0.000302	0.00523	CbGeAlD
Dronedarone—ADRA2C—adrenal gland—breast cancer	0.000298	0.00516	CbGeAlD
Dronedarone—ADRA2A—endometrium—breast cancer	0.000294	0.00509	CbGeAlD
Dronedarone—KCNH2—bone marrow—breast cancer	0.000292	0.00506	CbGeAlD
Dronedarone—KCNH2—female gonad—breast cancer	0.000282	0.00487	CbGeAlD
Dronedarone—ADRA2C—female gonad—breast cancer	0.000278	0.00481	CbGeAlD
Dronedarone—ADRA1A—endocrine gland—breast cancer	0.000271	0.00469	CbGeAlD
Dronedarone—ADRA2A—uterus—breast cancer	0.000271	0.00469	CbGeAlD
Dronedarone—Amiodarone—CYP2D6—breast cancer	0.00027	0.077	CrCbGaD
Dronedarone—ADRA2A—pituitary gland—breast cancer	0.000266	0.00461	CbGeAlD
Dronedarone—ADRA2A—adipose tissue—breast cancer	0.000265	0.00459	CbGeAlD
Dronedarone—KCNH2—endocrine gland—breast cancer	0.000262	0.00453	CbGeAlD
Dronedarone—ADRA2A—female reproductive system—breast cancer	0.000244	0.00422	CbGeAlD
Dronedarone—ADRA2A—adrenal gland—breast cancer	0.000238	0.00412	CbGeAlD
Dronedarone—ALB—lymph node—breast cancer	0.000236	0.00408	CbGeAlD
Dronedarone—Amiodarone—CYP3A4—breast cancer	0.000231	0.066	CrCbGaD
Dronedarone—ABCB1—embryo—breast cancer	0.000224	0.00388	CbGeAlD
Dronedarone—ADRA2A—female gonad—breast cancer	0.000222	0.00384	CbGeAlD
Dronedarone—ADRA2A—endocrine gland—breast cancer	0.000206	0.00357	CbGeAlD
Dronedarone—Amiodarone—ABCB1—breast cancer	0.000193	0.055	CrCbGaD
Dronedarone—CYP3A4—female reproductive system—breast cancer	0.000192	0.00332	CbGeAlD
Dronedarone—CYP2D6—female reproductive system—breast cancer	0.000189	0.00327	CbGeAlD
Dronedarone—ABCB1—epithelium—breast cancer	0.000183	0.00316	CbGeAlD
Dronedarone—KCNH2—lymph node—breast cancer	0.000181	0.00313	CbGeAlD
Dronedarone—ADRA2C—lymph node—breast cancer	0.000179	0.00309	CbGeAlD
Dronedarone—CYP2D6—female gonad—breast cancer	0.000172	0.00297	CbGeAlD
Dronedarone—Cardiac failure congestive—Epirubicin—breast cancer	0.000165	0.00102	CcSEcCtD
Dronedarone—Fatigue—Vinorelbine—breast cancer	0.000164	0.00102	CcSEcCtD
Dronedarone—ABCB1—endometrium—breast cancer	0.000164	0.00284	CbGeAlD
Dronedarone—Angiopathy—Paclitaxel—breast cancer	0.000164	0.00102	CcSEcCtD
Dronedarone—Immune system disorder—Paclitaxel—breast cancer	0.000163	0.00101	CcSEcCtD
Dronedarone—Mediastinal disorder—Paclitaxel—breast cancer	0.000163	0.00101	CcSEcCtD
Dronedarone—CYP3A4—endocrine gland—breast cancer	0.000162	0.00281	CbGeAlD
Dronedarone—Hepatobiliary disease—Docetaxel—breast cancer	0.000161	0.000999	CcSEcCtD
Dronedarone—Dyspepsia—Thiotepa—breast cancer	0.00016	0.000994	CcSEcCtD
Dronedarone—Asthenia—Tamoxifen—breast cancer	0.00016	0.000992	CcSEcCtD
Dronedarone—CYP2D6—endocrine gland—breast cancer	0.00016	0.00276	CbGeAlD
Dronedarone—Vomiting—Chlorambucil—breast cancer	0.000159	0.000987	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000159	0.000984	CcSEcCtD
Dronedarone—Pruritus—Tamoxifen—breast cancer	0.000158	0.000978	CcSEcCtD
Dronedarone—Anaphylactic shock—Irinotecan—breast cancer	0.000157	0.000975	CcSEcCtD
Dronedarone—Anaphylactic shock—Mitoxantrone—breast cancer	0.000157	0.000975	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Thiotepa—breast cancer	0.000157	0.000975	CcSEcCtD
Dronedarone—Erythema—Paclitaxel—breast cancer	0.000157	0.000974	CcSEcCtD
Dronedarone—Fatigue—Thiotepa—breast cancer	0.000157	0.000973	CcSEcCtD
Dronedarone—Diarrhoea—Vinblastine—breast cancer	0.000157	0.000973	CcSEcCtD
Dronedarone—Asthenia—Melphalan—breast cancer	0.000157	0.000971	CcSEcCtD
Dronedarone—Hepatobiliary disease—Capecitabine—breast cancer	0.000156	0.000968	CcSEcCtD
Dronedarone—Gastrointestinal pain—Vinorelbine—breast cancer	0.000156	0.000967	CcSEcCtD
Dronedarone—Pruritus—Melphalan—breast cancer	0.000154	0.000957	CcSEcCtD
Dronedarone—Nervous system disorder—Irinotecan—breast cancer	0.000154	0.000956	CcSEcCtD
Dronedarone—Dysgeusia—Paclitaxel—breast cancer	0.000154	0.000954	CcSEcCtD
Dronedarone—Eczema—Doxorubicin—breast cancer	0.000154	0.000952	CcSEcCtD
Dronedarone—Anaphylactic shock—Gemcitabine—breast cancer	0.000153	0.00095	CcSEcCtD
Dronedarone—Cardiac failure—Epirubicin—breast cancer	0.000153	0.000948	CcSEcCtD
Dronedarone—Asthenia—Goserelin—breast cancer	0.000153	0.000947	CcSEcCtD
Dronedarone—Skin disorder—Mitoxantrone—breast cancer	0.000153	0.000947	CcSEcCtD
Dronedarone—Diarrhoea—Tamoxifen—breast cancer	0.000153	0.000946	CcSEcCtD
Dronedarone—Cardiac failure congestive—Doxorubicin—breast cancer	0.000152	0.000944	CcSEcCtD
Dronedarone—ABCB1—uterus—breast cancer	0.000151	0.00261	CbGeAlD
Dronedarone—Bradycardia—Capecitabine—breast cancer	0.000151	0.000935	CcSEcCtD
Dronedarone—Abdominal pain—Vinorelbine—breast cancer	0.000151	0.000935	CcSEcCtD
Dronedarone—Pruritus—Goserelin—breast cancer	0.000151	0.000934	CcSEcCtD
Dronedarone—Anaphylactic shock—Fluorouracil—breast cancer	0.000151	0.000934	CcSEcCtD
Dronedarone—Nervous system disorder—Gemcitabine—breast cancer	0.00015	0.000931	CcSEcCtD
Dronedarone—Diarrhoea—Melphalan—breast cancer	0.000149	0.000926	CcSEcCtD
Dronedarone—Gastrointestinal pain—Thiotepa—breast cancer	0.000149	0.000923	CcSEcCtD
Dronedarone—Skin disorder—Gemcitabine—breast cancer	0.000149	0.000922	CcSEcCtD
Dronedarone—Nausea—Chlorambucil—breast cancer	0.000149	0.000922	CcSEcCtD
Dronedarone—ABCB1—pituitary gland—breast cancer	0.000148	0.00257	CbGeAlD
Dronedarone—Nervous system disorder—Fluorouracil—breast cancer	0.000148	0.000916	CcSEcCtD
Dronedarone—ABCB1—adipose tissue—breast cancer	0.000148	0.00256	CbGeAlD
Dronedarone—Vomiting—Vinblastine—breast cancer	0.000146	0.000904	CcSEcCtD
Dronedarone—Diarrhoea—Goserelin—breast cancer	0.000146	0.000903	CcSEcCtD
Dronedarone—Abdominal pain—Thiotepa—breast cancer	0.000144	0.000892	CcSEcCtD
Dronedarone—Angioedema—Paclitaxel—breast cancer	0.000144	0.00089	CcSEcCtD
Dronedarone—ADRA2A—lymph node—breast cancer	0.000143	0.00247	CbGeAlD
Dronedarone—Cardiac disorder—Docetaxel—breast cancer	0.000142	0.00088	CcSEcCtD
Dronedarone—Vomiting—Tamoxifen—breast cancer	0.000142	0.000879	CcSEcCtD
Dronedarone—Cardiac failure—Doxorubicin—breast cancer	0.000142	0.000877	CcSEcCtD
Dronedarone—Rash—Tamoxifen—breast cancer	0.000141	0.000871	CcSEcCtD
Dronedarone—Dermatitis—Tamoxifen—breast cancer	0.00014	0.000871	CcSEcCtD
Dronedarone—Blood creatinine increased—Epirubicin—breast cancer	0.00014	0.000866	CcSEcCtD
Dronedarone—Angiopathy—Docetaxel—breast cancer	0.000139	0.000861	CcSEcCtD
Dronedarone—Vomiting—Melphalan—breast cancer	0.000139	0.00086	CcSEcCtD
Dronedarone—Dyspepsia—Irinotecan—breast cancer	0.000138	0.000858	CcSEcCtD
Dronedarone—Dyspepsia—Mitoxantrone—breast cancer	0.000138	0.000858	CcSEcCtD
Dronedarone—Immune system disorder—Docetaxel—breast cancer	0.000138	0.000857	CcSEcCtD
Dronedarone—Mediastinal disorder—Docetaxel—breast cancer	0.000138	0.000855	CcSEcCtD
Dronedarone—Rash—Melphalan—breast cancer	0.000138	0.000853	CcSEcCtD
Dronedarone—Cardiac disorder—Capecitabine—breast cancer	0.000138	0.000852	CcSEcCtD
Dronedarone—Dermatitis—Melphalan—breast cancer	0.000138	0.000852	CcSEcCtD
Dronedarone—Asthenia—Vinorelbine—breast cancer	0.000137	0.000848	CcSEcCtD
Dronedarone—Nausea—Vinblastine—breast cancer	0.000136	0.000845	CcSEcCtD
Dronedarone—Hypokalaemia—Epirubicin—breast cancer	0.000136	0.000842	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Irinotecan—breast cancer	0.000136	0.000842	CcSEcCtD
Dronedarone—ABCB1—female reproductive system—breast cancer	0.000136	0.00235	CbGeAlD
Dronedarone—Fatigue—Irinotecan—breast cancer	0.000136	0.000841	CcSEcCtD
Dronedarone—Fatigue—Mitoxantrone—breast cancer	0.000136	0.000841	CcSEcCtD
Dronedarone—Vomiting—Goserelin—breast cancer	0.000135	0.000839	CcSEcCtD
Dronedarone—Pruritus—Vinorelbine—breast cancer	0.000135	0.000836	CcSEcCtD
Dronedarone—Angiopathy—Capecitabine—breast cancer	0.000134	0.000833	CcSEcCtD
Dronedarone—Rash—Goserelin—breast cancer	0.000134	0.000832	CcSEcCtD
Dronedarone—Dermatitis—Goserelin—breast cancer	0.000134	0.000831	CcSEcCtD
Dronedarone—Immune system disorder—Capecitabine—breast cancer	0.000134	0.00083	CcSEcCtD
Dronedarone—Mediastinal disorder—Capecitabine—breast cancer	0.000134	0.000828	CcSEcCtD
Dronedarone—Erythema—Docetaxel—breast cancer	0.000133	0.000826	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000133	0.000824	CcSEcCtD
Dronedarone—Dyspepsia—Fluorouracil—breast cancer	0.000133	0.000822	CcSEcCtD
Dronedarone—ABCB1—adrenal gland—breast cancer	0.000132	0.00229	CbGeAlD
Dronedarone—Nausea—Tamoxifen—breast cancer	0.000132	0.000821	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000132	0.00082	CcSEcCtD
Dronedarone—Fatigue—Gemcitabine—breast cancer	0.000132	0.000819	CcSEcCtD
Dronedarone—Asthenia—Thiotepa—breast cancer	0.000131	0.00081	CcSEcCtD
Dronedarone—Diarrhoea—Vinorelbine—breast cancer	0.000131	0.000809	CcSEcCtD
Dronedarone—Dysgeusia—Docetaxel—breast cancer	0.00013	0.000809	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Fluorouracil—breast cancer	0.00013	0.000806	CcSEcCtD
Dronedarone—Nausea—Melphalan—breast cancer	0.00013	0.000804	CcSEcCtD
Dronedarone—Blood creatinine increased—Doxorubicin—breast cancer	0.000129	0.000802	CcSEcCtD
Dronedarone—Erythema—Capecitabine—breast cancer	0.000129	0.0008	CcSEcCtD
Dronedarone—Pruritus—Thiotepa—breast cancer	0.000129	0.000799	CcSEcCtD
Dronedarone—Gastrointestinal pain—Irinotecan—breast cancer	0.000129	0.000797	CcSEcCtD
Dronedarone—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000129	0.000797	CcSEcCtD
Dronedarone—Anaphylactic shock—Paclitaxel—breast cancer	0.000128	0.000795	CcSEcCtD
Dronedarone—ABCB1—bone marrow—breast cancer	0.000128	0.00222	CbGeAlD
Dronedarone—Nausea—Goserelin—breast cancer	0.000127	0.000784	CcSEcCtD
Dronedarone—Dysgeusia—Capecitabine—breast cancer	0.000126	0.000783	CcSEcCtD
Dronedarone—Nervous system disorder—Paclitaxel—breast cancer	0.000126	0.00078	CcSEcCtD
Dronedarone—Photosensitivity reaction—Methotrexate—breast cancer	0.000126	0.00078	CcSEcCtD
Dronedarone—Hypokalaemia—Doxorubicin—breast cancer	0.000126	0.000779	CcSEcCtD
Dronedarone—Diarrhoea—Thiotepa—breast cancer	0.000125	0.000772	CcSEcCtD
Dronedarone—Skin disorder—Paclitaxel—breast cancer	0.000125	0.000772	CcSEcCtD
Dronedarone—Abdominal pain—Mitoxantrone—breast cancer	0.000124	0.000771	CcSEcCtD
Dronedarone—Abdominal pain—Irinotecan—breast cancer	0.000124	0.000771	CcSEcCtD
Dronedarone—Pneumonia—Methotrexate—breast cancer	0.000124	0.000766	CcSEcCtD
Dronedarone—ABCB1—female gonad—breast cancer	0.000124	0.00214	CbGeAlD
Dronedarone—Vomiting—Vinorelbine—breast cancer	0.000121	0.000752	CcSEcCtD
Dronedarone—Rash—Vinorelbine—breast cancer	0.00012	0.000745	CcSEcCtD
Dronedarone—Dermatitis—Vinorelbine—breast cancer	0.00012	0.000745	CcSEcCtD
Dronedarone—Photosensitivity reaction—Epirubicin—breast cancer	0.000118	0.00073	CcSEcCtD
Dronedarone—Hepatobiliary disease—Methotrexate—breast cancer	0.000116	0.00072	CcSEcCtD
Dronedarone—Vomiting—Thiotepa—breast cancer	0.000116	0.000718	CcSEcCtD
Dronedarone—Pneumonia—Epirubicin—breast cancer	0.000116	0.000717	CcSEcCtD
Dronedarone—Rash—Thiotepa—breast cancer	0.000115	0.000712	CcSEcCtD
Dronedarone—ABCB1—endocrine gland—breast cancer	0.000115	0.00199	CbGeAlD
Dronedarone—Dermatitis—Thiotepa—breast cancer	0.000115	0.000711	CcSEcCtD
Dronedarone—Nausea—Vinorelbine—breast cancer	0.000113	0.000702	CcSEcCtD
Dronedarone—Dyspepsia—Paclitaxel—breast cancer	0.000113	0.0007	CcSEcCtD
Dronedarone—Asthenia—Mitoxantrone—breast cancer	0.000113	0.0007	CcSEcCtD
Dronedarone—Asthenia—Irinotecan—breast cancer	0.000113	0.0007	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000113	0.000698	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000111	0.000686	CcSEcCtD
Dronedarone—Fatigue—Paclitaxel—breast cancer	0.000111	0.000686	CcSEcCtD
Dronedarone—Asthenia—Gemcitabine—breast cancer	0.00011	0.000681	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000109	0.000676	CcSEcCtD
Dronedarone—Photosensitivity reaction—Doxorubicin—breast cancer	0.000109	0.000675	CcSEcCtD
Dronedarone—Hepatobiliary disease—Epirubicin—breast cancer	0.000109	0.000674	CcSEcCtD
Dronedarone—Anaphylactic shock—Docetaxel—breast cancer	0.000109	0.000674	CcSEcCtD
Dronedarone—Pruritus—Gemcitabine—breast cancer	0.000108	0.000672	CcSEcCtD
Dronedarone—Nausea—Thiotepa—breast cancer	0.000108	0.000671	CcSEcCtD
Dronedarone—Diarrhoea—Mitoxantrone—breast cancer	0.000108	0.000667	CcSEcCtD
Dronedarone—Diarrhoea—Irinotecan—breast cancer	0.000108	0.000667	CcSEcCtD
Dronedarone—Pneumonia—Doxorubicin—breast cancer	0.000107	0.000663	CcSEcCtD
Dronedarone—Nervous system disorder—Docetaxel—breast cancer	0.000107	0.000661	CcSEcCtD
Dronedarone—Pruritus—Fluorouracil—breast cancer	0.000107	0.000661	CcSEcCtD
Dronedarone—Skin disorder—Docetaxel—breast cancer	0.000106	0.000655	CcSEcCtD
Dronedarone—Bradycardia—Epirubicin—breast cancer	0.000105	0.000651	CcSEcCtD
Dronedarone—Gastrointestinal pain—Paclitaxel—breast cancer	0.000105	0.00065	CcSEcCtD
Dronedarone—Diarrhoea—Gemcitabine—breast cancer	0.000105	0.00065	CcSEcCtD
Dronedarone—Nervous system disorder—Capecitabine—breast cancer	0.000103	0.00064	CcSEcCtD
Dronedarone—Diarrhoea—Fluorouracil—breast cancer	0.000103	0.000639	CcSEcCtD
Dronedarone—Cardiac disorder—Methotrexate—breast cancer	0.000102	0.000635	CcSEcCtD
Dronedarone—Skin disorder—Capecitabine—breast cancer	0.000102	0.000634	CcSEcCtD
Dronedarone—Abdominal pain—Paclitaxel—breast cancer	0.000101	0.000629	CcSEcCtD
Dronedarone—Hepatobiliary disease—Doxorubicin—breast cancer	0.000101	0.000624	CcSEcCtD
Dronedarone—Angiopathy—Methotrexate—breast cancer	0.0001	0.00062	CcSEcCtD
Dronedarone—Vomiting—Mitoxantrone—breast cancer	0.0001	0.00062	CcSEcCtD
Dronedarone—Vomiting—Irinotecan—breast cancer	0.0001	0.00062	CcSEcCtD
Dronedarone—Immune system disorder—Methotrexate—breast cancer	9.97e-05	0.000618	CcSEcCtD
Dronedarone—Mediastinal disorder—Methotrexate—breast cancer	9.94e-05	0.000616	CcSEcCtD
Dronedarone—Rash—Irinotecan—breast cancer	9.92e-05	0.000615	CcSEcCtD
Dronedarone—Rash—Mitoxantrone—breast cancer	9.92e-05	0.000615	CcSEcCtD
Dronedarone—Dermatitis—Mitoxantrone—breast cancer	9.91e-05	0.000614	CcSEcCtD
Dronedarone—Dermatitis—Irinotecan—breast cancer	9.91e-05	0.000614	CcSEcCtD
Dronedarone—Vomiting—Gemcitabine—breast cancer	9.74e-05	0.000604	CcSEcCtD
Dronedarone—Bradycardia—Doxorubicin—breast cancer	9.73e-05	0.000603	CcSEcCtD
Dronedarone—Rash—Gemcitabine—breast cancer	9.66e-05	0.000599	CcSEcCtD
Dronedarone—Dermatitis—Gemcitabine—breast cancer	9.65e-05	0.000598	CcSEcCtD
Dronedarone—Erythema—Methotrexate—breast cancer	9.6e-05	0.000595	CcSEcCtD
Dronedarone—Cardiac disorder—Epirubicin—breast cancer	9.58e-05	0.000594	CcSEcCtD
Dronedarone—Vomiting—Fluorouracil—breast cancer	9.58e-05	0.000594	CcSEcCtD
Dronedarone—Dyspepsia—Docetaxel—breast cancer	9.57e-05	0.000593	CcSEcCtD
Dronedarone—Rash—Fluorouracil—breast cancer	9.5e-05	0.000589	CcSEcCtD
Dronedarone—Dermatitis—Fluorouracil—breast cancer	9.49e-05	0.000588	CcSEcCtD
Dronedarone—Dysgeusia—Methotrexate—breast cancer	9.41e-05	0.000583	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Docetaxel—breast cancer	9.39e-05	0.000582	CcSEcCtD
Dronedarone—Fatigue—Docetaxel—breast cancer	9.38e-05	0.000581	CcSEcCtD
Dronedarone—Angiopathy—Epirubicin—breast cancer	9.37e-05	0.000581	CcSEcCtD
Dronedarone—Nausea—Irinotecan—breast cancer	9.35e-05	0.000579	CcSEcCtD
Dronedarone—Nausea—Mitoxantrone—breast cancer	9.35e-05	0.000579	CcSEcCtD
Dronedarone—Immune system disorder—Epirubicin—breast cancer	9.33e-05	0.000578	CcSEcCtD
Dronedarone—Mediastinal disorder—Epirubicin—breast cancer	9.31e-05	0.000577	CcSEcCtD
Dronedarone—Dyspepsia—Capecitabine—breast cancer	9.27e-05	0.000574	CcSEcCtD
Dronedarone—Asthenia—Paclitaxel—breast cancer	9.21e-05	0.000571	CcSEcCtD
Dronedarone—Nausea—Gemcitabine—breast cancer	9.1e-05	0.000564	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Capecitabine—breast cancer	9.09e-05	0.000563	CcSEcCtD
Dronedarone—Fatigue—Capecitabine—breast cancer	9.08e-05	0.000563	CcSEcCtD
Dronedarone—Pruritus—Paclitaxel—breast cancer	9.08e-05	0.000563	CcSEcCtD
Dronedarone—Erythema—Epirubicin—breast cancer	8.99e-05	0.000557	CcSEcCtD
Dronedarone—Nausea—Fluorouracil—breast cancer	8.95e-05	0.000555	CcSEcCtD
Dronedarone—Gastrointestinal pain—Docetaxel—breast cancer	8.89e-05	0.000551	CcSEcCtD
Dronedarone—Cardiac disorder—Doxorubicin—breast cancer	8.87e-05	0.000549	CcSEcCtD
Dronedarone—Dysgeusia—Epirubicin—breast cancer	8.8e-05	0.000545	CcSEcCtD
Dronedarone—Diarrhoea—Paclitaxel—breast cancer	8.78e-05	0.000544	CcSEcCtD
Dronedarone—Angiopathy—Doxorubicin—breast cancer	8.67e-05	0.000537	CcSEcCtD
Dronedarone—Immune system disorder—Doxorubicin—breast cancer	8.63e-05	0.000535	CcSEcCtD
Dronedarone—Gastrointestinal pain—Capecitabine—breast cancer	8.61e-05	0.000534	CcSEcCtD
Dronedarone—Mediastinal disorder—Doxorubicin—breast cancer	8.61e-05	0.000534	CcSEcCtD
Dronedarone—Abdominal pain—Docetaxel—breast cancer	8.6e-05	0.000533	CcSEcCtD
Dronedarone—Abdominal pain—Capecitabine—breast cancer	8.32e-05	0.000516	CcSEcCtD
Dronedarone—Erythema—Doxorubicin—breast cancer	8.32e-05	0.000515	CcSEcCtD
Dronedarone—Vomiting—Paclitaxel—breast cancer	8.16e-05	0.000506	CcSEcCtD
Dronedarone—Dysgeusia—Doxorubicin—breast cancer	8.14e-05	0.000505	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	8.12e-05	0.000503	CcSEcCtD
Dronedarone—Rash—Paclitaxel—breast cancer	8.09e-05	0.000501	CcSEcCtD
Dronedarone—Dermatitis—Paclitaxel—breast cancer	8.08e-05	0.000501	CcSEcCtD
Dronedarone—ABCB1—lymph node—breast cancer	7.94e-05	0.00137	CbGeAlD
Dronedarone—Anaphylactic shock—Methotrexate—breast cancer	7.84e-05	0.000486	CcSEcCtD
Dronedarone—Asthenia—Docetaxel—breast cancer	7.8e-05	0.000484	CcSEcCtD
Dronedarone—Pruritus—Docetaxel—breast cancer	7.69e-05	0.000477	CcSEcCtD
Dronedarone—Nervous system disorder—Methotrexate—breast cancer	7.69e-05	0.000476	CcSEcCtD
Dronedarone—Nausea—Paclitaxel—breast cancer	7.62e-05	0.000472	CcSEcCtD
Dronedarone—Skin disorder—Methotrexate—breast cancer	7.61e-05	0.000472	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	7.6e-05	0.000471	CcSEcCtD
Dronedarone—Asthenia—Capecitabine—breast cancer	7.55e-05	0.000468	CcSEcCtD
Dronedarone—Pruritus—Capecitabine—breast cancer	7.45e-05	0.000462	CcSEcCtD
Dronedarone—Diarrhoea—Docetaxel—breast cancer	7.44e-05	0.000461	CcSEcCtD
Dronedarone—Anaphylactic shock—Epirubicin—breast cancer	7.34e-05	0.000455	CcSEcCtD
Dronedarone—Diarrhoea—Capecitabine—breast cancer	7.2e-05	0.000446	CcSEcCtD
Dronedarone—Nervous system disorder—Epirubicin—breast cancer	7.19e-05	0.000446	CcSEcCtD
Dronedarone—Skin disorder—Epirubicin—breast cancer	7.13e-05	0.000442	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	7.03e-05	0.000436	CcSEcCtD
Dronedarone—Vomiting—Docetaxel—breast cancer	6.91e-05	0.000429	CcSEcCtD
Dronedarone—Dyspepsia—Methotrexate—breast cancer	6.9e-05	0.000428	CcSEcCtD
Dronedarone—Rash—Docetaxel—breast cancer	6.86e-05	0.000425	CcSEcCtD
Dronedarone—Dermatitis—Docetaxel—breast cancer	6.85e-05	0.000425	CcSEcCtD
Dronedarone—Anaphylactic shock—Doxorubicin—breast cancer	6.79e-05	0.000421	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Methotrexate—breast cancer	6.77e-05	0.000419	CcSEcCtD
Dronedarone—Fatigue—Methotrexate—breast cancer	6.76e-05	0.000419	CcSEcCtD
Dronedarone—Vomiting—Capecitabine—breast cancer	6.69e-05	0.000415	CcSEcCtD
Dronedarone—Nervous system disorder—Doxorubicin—breast cancer	6.66e-05	0.000412	CcSEcCtD
Dronedarone—Rash—Capecitabine—breast cancer	6.64e-05	0.000411	CcSEcCtD
Dronedarone—Dermatitis—Capecitabine—breast cancer	6.63e-05	0.000411	CcSEcCtD
Dronedarone—Skin disorder—Doxorubicin—breast cancer	6.59e-05	0.000409	CcSEcCtD
Dronedarone—Nausea—Docetaxel—breast cancer	6.46e-05	0.0004	CcSEcCtD
Dronedarone—Dyspepsia—Epirubicin—breast cancer	6.46e-05	0.0004	CcSEcCtD
Dronedarone—Gastrointestinal pain—Methotrexate—breast cancer	6.41e-05	0.000397	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Epirubicin—breast cancer	6.33e-05	0.000392	CcSEcCtD
Dronedarone—Fatigue—Epirubicin—breast cancer	6.32e-05	0.000392	CcSEcCtD
Dronedarone—Nausea—Capecitabine—breast cancer	6.25e-05	0.000388	CcSEcCtD
Dronedarone—Abdominal pain—Methotrexate—breast cancer	6.2e-05	0.000384	CcSEcCtD
Dronedarone—Gastrointestinal pain—Epirubicin—breast cancer	6e-05	0.000372	CcSEcCtD
Dronedarone—Dyspepsia—Doxorubicin—breast cancer	5.97e-05	0.00037	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Doxorubicin—breast cancer	5.86e-05	0.000363	CcSEcCtD
Dronedarone—Fatigue—Doxorubicin—breast cancer	5.85e-05	0.000363	CcSEcCtD
Dronedarone—Abdominal pain—Epirubicin—breast cancer	5.8e-05	0.000359	CcSEcCtD
Dronedarone—Asthenia—Methotrexate—breast cancer	5.62e-05	0.000349	CcSEcCtD
Dronedarone—Gastrointestinal pain—Doxorubicin—breast cancer	5.55e-05	0.000344	CcSEcCtD
Dronedarone—Pruritus—Methotrexate—breast cancer	5.55e-05	0.000344	CcSEcCtD
Dronedarone—Abdominal pain—Doxorubicin—breast cancer	5.37e-05	0.000333	CcSEcCtD
Dronedarone—Diarrhoea—Methotrexate—breast cancer	5.36e-05	0.000332	CcSEcCtD
Dronedarone—Asthenia—Epirubicin—breast cancer	5.26e-05	0.000326	CcSEcCtD
Dronedarone—Pruritus—Epirubicin—breast cancer	5.19e-05	0.000322	CcSEcCtD
Dronedarone—Diarrhoea—Epirubicin—breast cancer	5.02e-05	0.000311	CcSEcCtD
Dronedarone—Vomiting—Methotrexate—breast cancer	4.98e-05	0.000309	CcSEcCtD
Dronedarone—Rash—Methotrexate—breast cancer	4.94e-05	0.000306	CcSEcCtD
Dronedarone—Dermatitis—Methotrexate—breast cancer	4.94e-05	0.000306	CcSEcCtD
Dronedarone—Asthenia—Doxorubicin—breast cancer	4.87e-05	0.000302	CcSEcCtD
Dronedarone—Pruritus—Doxorubicin—breast cancer	4.8e-05	0.000298	CcSEcCtD
Dronedarone—Vomiting—Epirubicin—breast cancer	4.66e-05	0.000289	CcSEcCtD
Dronedarone—Nausea—Methotrexate—breast cancer	4.66e-05	0.000289	CcSEcCtD
Dronedarone—Diarrhoea—Doxorubicin—breast cancer	4.64e-05	0.000288	CcSEcCtD
Dronedarone—Rash—Epirubicin—breast cancer	4.63e-05	0.000287	CcSEcCtD
Dronedarone—Dermatitis—Epirubicin—breast cancer	4.62e-05	0.000286	CcSEcCtD
Dronedarone—Nausea—Epirubicin—breast cancer	4.36e-05	0.00027	CcSEcCtD
Dronedarone—Vomiting—Doxorubicin—breast cancer	4.32e-05	0.000267	CcSEcCtD
Dronedarone—Rash—Doxorubicin—breast cancer	4.28e-05	0.000265	CcSEcCtD
Dronedarone—Dermatitis—Doxorubicin—breast cancer	4.28e-05	0.000265	CcSEcCtD
Dronedarone—Nausea—Doxorubicin—breast cancer	4.03e-05	0.00025	CcSEcCtD
Dronedarone—ADRB1—Signaling Pathways—JUN—breast cancer	1.65e-06	1.2e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTGS2—breast cancer	1.65e-06	1.19e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CAV1—breast cancer	1.65e-06	1.19e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CXCL8—breast cancer	1.65e-06	1.19e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCND1—breast cancer	1.64e-06	1.19e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CTNNB1—breast cancer	1.64e-06	1.19e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—JUN—breast cancer	1.64e-06	1.19e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—HRAS—breast cancer	1.64e-06	1.18e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—SRC—breast cancer	1.63e-06	1.18e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CTNNB1—breast cancer	1.63e-06	1.18e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SLC2A1—breast cancer	1.63e-06	1.18e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NQO1—breast cancer	1.63e-06	1.18e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NOS3—breast cancer	1.62e-06	1.17e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CXCL8—breast cancer	1.62e-06	1.17e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—AKT1—breast cancer	1.61e-06	1.17e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—HRAS—breast cancer	1.61e-06	1.17e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MMP9—breast cancer	1.61e-06	1.16e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CDKN1B—breast cancer	1.61e-06	1.16e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CDKN1A—breast cancer	1.6e-06	1.16e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PTEN—breast cancer	1.6e-06	1.16e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	1.6e-06	1.16e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MMP9—breast cancer	1.6e-06	1.15e-05	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—AKT1—breast cancer	1.59e-06	1.15e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CDKN1A—breast cancer	1.59e-06	1.15e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—VEGFA—breast cancer	1.59e-06	1.15e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PTEN—breast cancer	1.59e-06	1.15e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	1.58e-06	1.15e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	1.58e-06	1.14e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	1.58e-06	1.14e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CASP3—breast cancer	1.58e-06	1.14e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL2—breast cancer	1.57e-06	1.14e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—STAT3—breast cancer	1.57e-06	1.14e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL6—breast cancer	1.57e-06	1.13e-05	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	1.57e-06	1.13e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MAPK8—breast cancer	1.57e-06	1.13e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—KRAS—breast cancer	1.56e-06	1.13e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—AKT1—breast cancer	1.56e-06	1.13e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP1B1—breast cancer	1.56e-06	1.13e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CAV1—breast cancer	1.55e-06	1.12e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CASP3—breast cancer	1.55e-06	1.12e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MAPK8—breast cancer	1.55e-06	1.12e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL2—breast cancer	1.55e-06	1.12e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—AKT1—breast cancer	1.55e-06	1.12e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	1.55e-06	1.12e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL6—breast cancer	1.54e-06	1.12e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MDM2—breast cancer	1.54e-06	1.11e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—RAF1—breast cancer	1.53e-06	1.11e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCND1—breast cancer	1.53e-06	1.11e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—JUN—breast cancer	1.53e-06	1.11e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.53e-06	1.11e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—RELA—breast cancer	1.53e-06	1.11e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CTNNB1—breast cancer	1.52e-06	1.1e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ERBB2—breast cancer	1.52e-06	1.1e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCND1—breast cancer	1.51e-06	1.09e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NOS3—breast cancer	1.51e-06	1.09e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CD—breast cancer	1.51e-06	1.09e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—JUN—breast cancer	1.51e-06	1.09e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CG—breast cancer	1.5e-06	1.09e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MAPK3—breast cancer	1.5e-06	1.09e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MTOR—breast cancer	1.5e-06	1.08e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	1.5e-06	1.08e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	1.5e-06	1.08e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MMP9—breast cancer	1.49e-06	1.08e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NCOA1—breast cancer	1.49e-06	1.08e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CDKN1A—breast cancer	1.48e-06	1.07e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—SRC—breast cancer	1.48e-06	1.07e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PTEN—breast cancer	1.48e-06	1.07e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—SRC—breast cancer	1.47e-06	1.06e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MMP9—breast cancer	1.47e-06	1.06e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP19A1—breast cancer	1.47e-06	1.06e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—STK11—breast cancer	1.47e-06	1.06e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	1.46e-06	1.06e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MYC—breast cancer	1.46e-06	1.06e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PTEN—breast cancer	1.46e-06	1.05e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TGFB1—breast cancer	1.46e-06	1.05e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MAPK8—breast cancer	1.45e-06	1.05e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—VEGFA—breast cancer	1.45e-06	1.05e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—AKT1—breast cancer	1.45e-06	1.05e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CXCL8—breast cancer	1.44e-06	1.04e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTEN—breast cancer	1.44e-06	1.04e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	1.44e-06	1.04e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—VEGFA—breast cancer	1.43e-06	1.04e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—STAT3—breast cancer	1.43e-06	1.04e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MDM2—breast cancer	1.43e-06	1.04e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—HRAS—breast cancer	1.43e-06	1.03e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EGFR—breast cancer	1.43e-06	1.03e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MAPK8—breast cancer	1.43e-06	1.03e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—RAF1—breast cancer	1.43e-06	1.03e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—NOS3—breast cancer	1.42e-06	1.03e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—AKT1—breast cancer	1.42e-06	1.03e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—RELA—breast cancer	1.42e-06	1.03e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—STAT3—breast cancer	1.42e-06	1.03e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CG—breast cancer	1.42e-06	1.02e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ERBB2—breast cancer	1.41e-06	1.02e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	1.41e-06	1.02e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	1.39e-06	1.01e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MTOR—breast cancer	1.39e-06	1.01e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	1.39e-06	1.01e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CASP3—breast cancer	1.38e-06	9.97e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL2—breast cancer	1.38e-06	9.96e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—SRC—breast cancer	1.37e-06	9.94e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL6—breast cancer	1.37e-06	9.91e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MAPK3—breast cancer	1.37e-06	9.89e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—COMT—breast cancer	1.36e-06	9.86e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTP1—breast cancer	1.36e-06	9.82e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MAPK3—breast cancer	1.35e-06	9.8e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—SRC—breast cancer	1.35e-06	9.78e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—KRAS—breast cancer	1.35e-06	9.76e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCND1—breast cancer	1.34e-06	9.71e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—JUN—breast cancer	1.34e-06	9.68e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—HMOX1—breast cancer	1.34e-06	9.68e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.34e-06	9.68e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—VEGFA—breast cancer	1.34e-06	9.68e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ITPR1—breast cancer	1.34e-06	9.66e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MYC—breast cancer	1.33e-06	9.62e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.33e-06	9.62e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	1.33e-06	9.61e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TGFB1—breast cancer	1.33e-06	9.6e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—STAT3—breast cancer	1.32e-06	9.58e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CD—breast cancer	1.32e-06	9.56e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MYC—breast cancer	1.32e-06	9.53e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—VEGFA—breast cancer	1.32e-06	9.53e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TGFB1—breast cancer	1.31e-06	9.51e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CB—breast cancer	1.31e-06	9.51e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.31e-06	9.45e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—ALB—breast cancer	1.3e-06	9.43e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—STAT3—breast cancer	1.3e-06	9.43e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MMP9—breast cancer	1.3e-06	9.42e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTGS2—breast cancer	1.3e-06	9.42e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EGFR—breast cancer	1.3e-06	9.41e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	1.3e-06	9.39e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PTEN—breast cancer	1.29e-06	9.37e-06	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.29e-06	9.35e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EGFR—breast cancer	1.29e-06	9.32e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ABCB1—breast cancer	1.28e-06	9.29e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.28e-06	9.26e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL2—breast cancer	1.28e-06	9.25e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.27e-06	9.2e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.27e-06	9.16e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MAPK3—breast cancer	1.27e-06	9.16e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.26e-06	9.14e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—TYMS—breast cancer	1.26e-06	9.12e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PIK3CA—breast cancer	1.25e-06	9.04e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—NOS3—breast cancer	1.25e-06	9.02e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.25e-06	9.02e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTM1—breast cancer	1.25e-06	9.02e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NCOR1—breast cancer	1.25e-06	9.02e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.25e-06	9.02e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MAPK3—breast cancer	1.25e-06	9.01e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CD—breast cancer	1.24e-06	9.01e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—JUN—breast cancer	1.24e-06	9e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	1.24e-06	8.96e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.23e-06	8.93e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MYC—breast cancer	1.23e-06	8.9e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—KRAS—breast cancer	1.23e-06	8.89e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ALB—breast cancer	1.23e-06	8.89e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TGFB1—breast cancer	1.23e-06	8.88e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—KRAS—breast cancer	1.22e-06	8.81e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MYC—breast cancer	1.21e-06	8.76e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.21e-06	8.75e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TGFB1—breast cancer	1.21e-06	8.74e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.21e-06	8.72e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EGFR—breast cancer	1.2e-06	8.71e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.2e-06	8.7e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—SRC—breast cancer	1.2e-06	8.69e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TP53—breast cancer	1.2e-06	8.67e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GPX1—breast cancer	1.19e-06	8.64e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EGFR—breast cancer	1.18e-06	8.57e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP1A1—breast cancer	1.18e-06	8.55e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.18e-06	8.51e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—NOS3—breast cancer	1.18e-06	8.5e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.17e-06	8.49e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ERCC2—breast cancer	1.17e-06	8.48e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—VEGFA—breast cancer	1.17e-06	8.46e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—STAT3—breast cancer	1.16e-06	8.38e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CB—breast cancer	1.15e-06	8.33e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—HRAS—breast cancer	1.15e-06	8.29e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTGS2—breast cancer	1.14e-06	8.25e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—KRAS—breast cancer	1.14e-06	8.23e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTEN—breast cancer	1.14e-06	8.21e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PIK3CA—breast cancer	1.13e-06	8.17e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—KRAS—breast cancer	1.12e-06	8.1e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	1.12e-06	8.09e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SRC—breast cancer	1.12e-06	8.07e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MAPK3—breast cancer	1.11e-06	8e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—MTHFR—breast cancer	1.1e-06	7.97e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL6—breast cancer	1.1e-06	7.94e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TP53—breast cancer	1.09e-06	7.9e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.09e-06	7.86e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CB—breast cancer	1.09e-06	7.85e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TP53—breast cancer	1.08e-06	7.83e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MYC—breast cancer	1.08e-06	7.78e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.08e-06	7.78e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTGS2—breast cancer	1.08e-06	7.78e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TGFB1—breast cancer	1.07e-06	7.77e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EGFR—breast cancer	1.05e-06	7.61e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	1.04e-06	7.56e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—HRAS—breast cancer	1.04e-06	7.56e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—HRAS—breast cancer	1.04e-06	7.49e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	1.03e-06	7.44e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.03e-06	7.44e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—AKT1—breast cancer	1.02e-06	7.39e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CAV1—breast cancer	1.02e-06	7.35e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PIK3CA—breast cancer	1.02e-06	7.34e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—AKT1—breast cancer	1.01e-06	7.32e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TP53—breast cancer	1.01e-06	7.31e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MYC—breast cancer	1e-06	7.23e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL6—breast cancer	1e-06	7.23e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TGFB1—breast cancer	9.97e-07	7.22e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTEN—breast cancer	9.95e-07	7.2e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TP53—breast cancer	9.95e-07	7.2e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—KRAS—breast cancer	9.94e-07	7.19e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL6—breast cancer	9.91e-07	7.17e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EGFR—breast cancer	9.78e-07	7.07e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—HRAS—breast cancer	9.67e-07	6.99e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—HRAS—breast cancer	9.52e-07	6.88e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTEN—breast cancer	9.38e-07	6.78e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CG—breast cancer	9.26e-07	6.7e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL6—breast cancer	9.25e-07	6.69e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—KRAS—breast cancer	9.24e-07	6.68e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—AKT1—breast cancer	9.22e-07	6.67e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—AKT1—breast cancer	9.14e-07	6.61e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	9.14e-07	6.61e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL6—breast cancer	9.11e-07	6.59e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TP53—breast cancer	8.84e-07	6.39e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—AKT1—breast cancer	8.54e-07	6.18e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	8.49e-07	6.14e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—HRAS—breast cancer	8.45e-07	6.11e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—AKT1—breast cancer	8.4e-07	6.08e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—AKT1—breast cancer	8.29e-07	6e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TP53—breast cancer	8.21e-07	5.94e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CD—breast cancer	8.14e-07	5.89e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL6—breast cancer	8.09e-07	5.85e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ALB—breast cancer	8.03e-07	5.81e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CA—breast cancer	8.01e-07	5.8e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HRAS—breast cancer	7.85e-07	5.68e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NOS3—breast cancer	7.69e-07	5.56e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL6—breast cancer	7.52e-07	5.44e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—AKT1—breast cancer	7.46e-07	5.4e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CB—breast cancer	7.09e-07	5.13e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTGS2—breast cancer	7.03e-07	5.08e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CA—breast cancer	7.02e-07	5.08e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—AKT1—breast cancer	6.93e-07	5.02e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CA—breast cancer	6.61e-07	4.78e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—AKT1—breast cancer	6.54e-07	4.73e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTEN—breast cancer	6.13e-07	4.43e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—AKT1—breast cancer	5.73e-07	4.15e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—AKT1—breast cancer	5.4e-07	3.91e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CA—breast cancer	4.32e-07	3.13e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—AKT1—breast cancer	3.53e-07	2.56e-06	CbGpPWpGaD
